Présentation :

Marie-Louise Schleck est pharmacien biologiste diplômée de l’Université de Liège et spécialisée dans les secteurs de chimie clinique (automatisée et manuelle) ainsi que POCT (Point-of-Care Testing) du LaboCita. 
Après obtention en 2019 du Diplôme inter-universitaire de transfusion sanguine à l’Université Paris Descartes, elle est également co-responsable du secteur d’immuno-hématologie.   
Elle supervise les projets du service informatique du Laboratoire.  
 

Spécialité(s) :

POINT-OF-CARE (POCT), CHIMIE CLINIQUE AUTOMATISÉE ET MANUELLE, IMMUNO-HÉMATOLOGIE

Localisation(s) :

• Citadelle

• “Spurious intraoperative PTH results observed with 2nd, but not with 3rd generation PTH assays” Etienne CAVALIER, Marie-Louise SCHLECK, Jean-Claude SOUBERBIELLE Clinica Chimica Acta, 477, 72–73, 2018
• “Parathormone Stability in Hemodialyzed Patients and Healthy Subjects: Comparison on Non-Centrifuged EDTA and Serum Samples with 2nd and 3rd Generation Assays” Marie-Louise SCHLECK, Jean-Claude SOUBERBIELLE, Pierre DELANAYE, Mario PLEBANI, Etienne CAVALIER Clinical Chemistry and Laboratory medicine, 55 (8), 1152-1159, 2017
• “A Randomized, Double-Blind, Parallel Study to Evaluate the Dose-Response of Three Different Vitamin D Treatment Schemes on the 25-Hydroxyvitamin D Serum Concentration in Patients with Vitamin D Deficiency” Marie-Louise SCHLECK, Jean-Claude SOUBERBIELLE, Bernard JANDRAIN, André SCHEEN, Etienne CAVALIER Nutrients, 7, 5413-22, 2015
• “The Third/Second Generation PTH Assay Ratio as a Marker for Parathyroid Carcinoma: Evaluation Using an Automated Platform” Etienne CAVALIER, Daniela BETEA, Marie-Louise SCHLECK, Romy GADISSEUR, Laurent VROONEN, Pierre DELANAYE, Adrian Francis DALY, Albert BECKERS Journal of Clinical Endocrinology and Metabolism, 99(3), 453-7, 2014

• "Evaluation of the new Anti-Mullerian Hormone immunoassay on the Atellica® IM Analyzer from Siemens" M.-L. SCHLECK, G. BELLEAU, M. BELCHE, G. SQALLI, J.-M. MINON Présentation poster au congrès IFCC Euromedlab 2023, Rome, Italie.
• “Non-invasive fetal genotyping of RHCE C/c and E alleles in allo-immunized pregnant women: evaluation of a 7-year experience” Jean-Marc MINON, Marie-Louise SCHLECK, Jérôme DE MARCHIN, Jean-Marc SENTERRE, Frédéric CHANTRAINE Présentation poster au congrès Belgian Hematology Society General Annual Meeting 2019, Bruxelles, Belgique.
• “Rapid detection of Streptococcus pyogenes and Streptococcus dysgalactiae in throat samples by real-time PCR” Marie-Louise SCHLECK, Jean-Marc SENTERRE Présentation poster au congrès ECCMID 2019, Amsterdam, Pays-Bas.
• “Cord blood cells: a rapid alternative method for antibody screening in patients under therapeutic CD38-targeting antibody (Daratumumab)” Marie-Louise SCHLECK, Olivia DE MOS, Mélanie MONFORT Vox Sanguinis, 113 (Suppl. 1), pp. S332, 2018. Présentation orale au congrès Belgian Hematology Society General Annual Meeting 2018, Bruxelles, Belgique Présentation poster au congrès International Society of Blood Transfusion (ISBT) 2018, Toronto, Canada
• “Intraoperative monitoring of Parathormone during surgery for primary hyperparathyroidism: a case report showing the importance to use a third generation Parathormone assay” Marie-Louise SCHLECK, Olivier ROUSSELLE, Nunzio FERRANTE, Pierre LUKAS, Etienne CAVALIER Clin Chem Lab Med, 55 (Special Suppl), pp. S286, June 2017. Présentation poster au congrès European Federation of Clinical Chemistry and Laboratory Medicine, EuroMedLab 2017, Athènes, Grèce
• “Establishment of the Intraindividual Coefficient Variation of Calcium, Phosphorus, 2nd generation PTH, 3rd generation PTH, intact Fibroblast Growth Factor 23, 25Hydroxy-vitaminD, Sclerostin, Myostatin and Activin A in healthy subjects” Marie-Louise SCHLECK, Etienne CAVALIER Présentation poster au congrès Annual Meeting of the Royal Belgian Society of Laboratory Medicine, 2016, Château du Val Saint-Lambert, Seraing, Belgique
• “Evaluation du débit de filtration glomérulaire estimé à l'aide d'un dosage de créatinine par analyseur de biologie délocalisé (Point of Care) ” Violeta STOJKOVIC, Marie-Louise SCHLECK, Etienne CAVALIER & Pierre DELANAYE Néphrologie & Thérapeutique, 12(5), 334, 2016
• “Parathormone Stability in Hemodialyzed Patients and Healthy Subjects: Comparison on Non-Centrifuged EDTA and Serum Samples with 2nd and 3rd Generation Assays” Etienne CAVALIER, Marie-Louise SCHLECK, Anne-Catherine BEKAERT, Nunzio FERRANTE, Olivier ROUSSELLE, Agnes CARLISI Osteoporosis International, vol. 27, no. 1, pp. 221, 2016 Présentation orale au congrès Annual Meeting of the Royal Belgian Society of Laboratory Medicine, 2015, U.L.B., Belgique
• “Suitability of 24,25(OH)2 vitamin D3 determination with an adapted version of the Chromsystems® MassChrom® 25-OH-Vitamin D3/D2– LC-MS/MS kit” Marie-Louise SCHLECK, Mathieu NETCHACOVITCH, Yannick CRINE, Stéphanie PEETERS, Pierre LUKAS, Etienne CAVALIER, Caroline LE GOFF Clinical Chemistry & Laboratory Medicine, 52 (Special Suppl), pp. 1235, 2014 Présentation Poster au congrès IFCC World Lab 2014, Istanbul, Turquie
• “Evaluation of the third-generation to second-generation PTH ratio on the Liaison XL® (DiaSorin) as a marker for parathyroid carcinoma” Marie-Louise SCHLECK, Terry LAURENT, Romy GADISSEUR, Agnes CARLISI, Olivier ROUSSELLE, Etienne CAVALIER Biochimica Clinica, 37 (Special Suppl), pp. S161, 2013